What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis
Emma Simpson(University of Sheffield), Richard J. Wakefield(University of Leeds), Emma Everson-Hock(University of Sheffield), Ruth Wong(National University of Singapore), Matt Stevenson(DuPont (United States)), Naila Dracup(University of Sheffield), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), C. Estrach(University of Liverpool), Philip G. Conaghan(University of Leeds), Allan Wailoo(University of Sheffield)
Cited by 29
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668